# A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.

> **NCT00291941** · PHASE3 · COMPLETED · sponsor: **Henogen** · enrollment: 300 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **BIOLOGICAL:** Henogen HBV vaccine
- **BIOLOGICAL:** FENDRIX

## Key facts

- **NCT ID:** NCT00291941
- **Lead sponsor:** Henogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2008-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00291941

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00291941, "A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00291941. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*